Our Approach

For many, allergy is considered a nuisance disease with low impact on cost compared to heart disease, diabetes, cancer and musculoskeletal issues. But allergy is a growing problem that impacts 20% of the population. Yet only five percent receives treatment that alters the underlying disease.

That means that of the roughly $100 billion spent on allergy each year, most of it is focused on temporary symptom reduction, overuse of urgent or emergency care, and treating issues that often escalate into more chronic, needlessly costly and critical conditions that may have been prevented with earlier intervention.

50 million — estimated U.S. allergic population

30 million — population with severe allergies or related disease (asthma, sinusitis, etc.)

4 million — those receiving disease-modifying allergy treatment


There is a better way to stop the spiraling costs of allergy.

The first step is uncovering the hidden cost of allergy and related conditions. Then, we help you develop an approach to minimize its impact.

Allergychoices' Allergy Control Program combines streamlined diagnostics and tailored treatment based on the evidence-based La Crosse Method™ Protocol. The published Protocol, proven in nearly 50 years of use and supporting research, guides diagnostics using reproducible skin or blood testing to identify a patient’s specific allergic “fingerprint,” and tailoring treatment to the patient’s problem allergens at their individual level of sensitivity.

Treatment delivering a precise dose of antigens under the tongue in liquid drop form (sublingual immunotherapy) stimulates the body’s immune tolerance mechanism. This enables each patient to receive a custom formulation based on their testing, and at a level that is therapeutic, but that doesn’t cause unnecessary reactions, and that can be taken at home — reducing medical utilization.

The combination allows the widest range of patients to be treated safely, effectively, affordably, and in a way that changes the disease — so ongoing symptoms and chronic related conditions can often be reduced or eliminated — along with spiraling costs.